The diabetes clinical trial landscape is evolving rapidly. As type 1 diabetes programs expand and innovative therapies, including cell and gene therapies, move into clinical development, sponsors face increasing operational complexity. At the same time, digital technologies such as continuous glucose monitoring (CGM), blood glucose monitoring (BGM), eDiaries and ePROs are generating significant volumes of patient data. The challenge is no longer simply collecting data but integrating these technologies into a study strategy that delivers high-quality, reliable outcomes. This webinar will explore practical approaches to executing modern diabetes clinical trials by combining therapeutic expertise with coordinated operational oversight.
Using examples from type 1 diabetes while drawing on broader experience across type 2 diabetes and other metabolic indications, the featured speakers will discuss how sponsors can successfully implement digital technologies without increasing operational burden.
Attendees will gain practical insights into overcoming common operational challenges, improving data quality and designing diabetes studies that are better positioned for successful execution. Whether planning an early-phase proof-of-concept study or a global pivotal program, participants will gain actionable strategies for navigating the increasing complexity of today’s diabetes clinical trial environment.
Register for this webinar to learn how operational oversight can support reliable data, integrated technology and successful diabetes clinical trial execution.
Global Diabetes Capabilities
With decades of experience across all phases of diabetes research, Medpace is a proven partner in the design and execution of clinical trials targeting type 1, type 2, and rare forms of diabetes. Our in-house endocrinologists, regulatory experts, and operational leaders provide strong therapeutic insight and hands-on collaboration to partner with Sponsors to address the unique challenges of endocrine and metabolic drug development.